SAG
BLFS icon

SageView Advisory Group’s BioLife Solutions BLFS Stock Holding History

SageView Advisory Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-138
Closed -$3.34K – 813
2025
Q4 		$3.34K Buy
+138
New +$3.61K ﹤0.01% 2076

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SageView Advisory Group's BLFS Position: Q1 2026 in Review

SageView Advisory Group sold out of BioLife Solutions (BLFS) in Q1 2026, closing a stake of 138 shares — an estimated $3.34K sold.

SageView Advisory Group first reported a position in BLFS in Q4 2025 and held it in 1 quarter. The position peaked at $3.34K in Q4 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • SageView Advisory Group reported no remaining BioLife Solutions position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 138 BioLife Solutions shares in Q1 2026, an estimated $3.34K.
  • SageView Advisory Group first reported a position in BioLife Solutions in Q4 2025 and held it in 1 quarter.
  • SageView Advisory Group's BioLife Solutions position peaked at $3.34K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.